Data search
Results for MligTC455_18091
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_18091 | 71 | 1.49 | Mlig455_014664 | Neo: - Age: - |
ARL3 | Mlig455_014664 {REF} {Length: 1771} {Pfam: ADP-ribosylation factor family [PF00025.23, score=67.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.6]; G-protein alpha subunit [PF00503.22, score=19.1]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=67.8, Expect=2e-13]; ENSG00000122644, ARL4A, ADP ribosylation factor like GTPase 4A, [Score=67.8, Expect=3e-13]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSG00000168374, ARF4, ADP ribosylation factor 4, [Score=65.1, Expect=2e-12]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=65.1, Expect=2e-12]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=64.7, Expect=4e-12]} {Mouse: ENSMUSG00000047446, Arl4a, ADP-ribosylation factor-like 4A, [Score=67.4, Expect=2e-13]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=66.6, Expect=4e-13]; ENSMUSG00000048076, Arf1, ADP-ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSMUSG00000051853, Arf3, ADP-ribosylation factor 3, [Score=65.1, Expect=1e-12]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=64.3, Expect=3e-12]} {Dmel: FBgn0013749, Arf102F, ADP ribosylation factor at 102F, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00000184, arf-6, ADP-Ribosylation Factor related, [Score=65.5, Expect=5e-13]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=78.6, Expect=7e-18]} {RNA1310_41790} {RNA815_35492} |
Cumulative graph for MligTC455_18091
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -6.439 | 1.52 | 0.15773 | 0.77686 | |
| RegionR2 | 2.711 | 1.52 | 0.04848 | 0.26162 | |
| RegionR3 | 0.682 | 1.52 | 0.59372 | 1.00000 | |
| RegionR4 | -0.224 | 1.52 | 0.93007 | 1.00000 | |
| RegionR5 | 0.942 | 1.52 | 0.44851 | 0.81035 | |
| RegionR6 | 1.281 | 1.52 | 0.33995 | 0.92732 | |
| RegionR7 | 1.125 | 1.52 | 0.42515 | 1.00000 | |
| RegionR8 | -0.078 | 1.52 | 0.92925 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.613 | 1.52 | 0.99998 | 1.00000 | |
| RegenerationR2 | -0.645 | 1.52 | 0.39421 | 0.81130 | |
| RegenerationR3 | 0.068 | 1.52 | 0.92929 | 1.00000 | |
| RegenerationR4 | 0.479 | 1.52 | 0.62741 | 0.92230 | |
| RegenerationR5 | -2.006 | 1.52 | 0.08347 | 0.44657 | |
| RegenerationR6 | -1.142 | 1.52 | 0.33953 | 0.68571 | |
| RegenerationBL | -0.444 | 1.52 | 0.77571 | 1.00000 | |
| RegenerationTP | -4.564 | 1.52 | 0.07861 | 0.44750 |
Genes with expression patterns similar to MligTC455_18091
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_18091 | 71 | 1.49 | Mlig455_014664 | Neo: - Age: - |
ARL3 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_014664 {REF} {Length: 1771} {Pfam: ADP-ribosylation factor family [PF00025.23, score=67.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.6]; G-protein alpha subunit [PF00503.22, score=19.1]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=67.8, Expect=2e-13]; ENSG00000122644, ARL4A, ADP ribosylation factor like GTPase 4A, [Score=67.8, Expect=3e-13]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSG00000168374, ARF4, ADP ribosylation factor 4, [Score=65.1, Expect=2e-12]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=65.1, Expect=2e-12]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=64.7, Expect=4e-12]} {Mouse: ENSMUSG00000047446, Arl4a, ADP-ribosylation factor-like 4A, [Score=67.4, Expect=2e-13]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=66.6, Expect=4e-13]; ENSMUSG00000048076, Arf1, ADP-ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSMUSG00000051853, Arf3, ADP-ribosylation factor 3, [Score=65.1, Expect=1e-12]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=64.3, Expect=3e-12]} {Dmel: FBgn0013749, Arf102F, ADP ribosylation factor at 102F, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00000184, arf-6, ADP-Ribosylation Factor related, [Score=65.5, Expect=5e-13]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=78.6, Expect=7e-18]} {RNA1310_41790} {RNA815_35492} |
| 2. | MligTC455_39078 | 130 | 2.7 | Mlig455_060090 | Neo: - Age: - |
2.665 | 0.878 | - | - | 0.834 | 0.953 | - | Mlig455_060090 {REF} {Length: 493} {NoTransDecoderORF} {RNA1509_45542} {RNA1310_46086} {RNA815_33321.1} | |
| 3. | MligTC455_15077 | 77 | 1.61 | Mlig455_042805 | Neo: Irradiation |
B3GNT6 | 2.635 | 0.973 | - | - | 0.784 | 0.878 | - | Mlig455_042805 {REF} {Length: 1985} {Pfam: Galactosyltransferase [PF01762.23, score=133.9]} {Human: ENSG00000198488, B3GNT6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, [Score=113, Expect=4e-27]; ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [Score=108, Expect=9e-26]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=111, Expect=1e-26]} {Dmel: FBgn0035558, CG11357, [Score=145, Expect=1e-38]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [Score=74.7, Expect=1e-14]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=239, Expect=2e-75]} {RNA1509_8878} {RNA1310_14228.1} {RNA815_4876} |
| 4. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
2.603 | 0.868 | - | - | 0.760 | 0.975 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
| 5. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 2.59 | 0.810 | - | - | 0.791 | 0.989 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
| 6. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 2.588 | 0.860 | - | - | 0.755 | 0.973 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
| 7. | MligTC455_19694 | 101 | 2.1 | Mlig455_019126 | Neo: - Age: - |
HMCN1 | 2.587 | 0.733 | - | - | 0.956 | 0.898 | - | Mlig455_019126 {REF} {Length: 1904} {Pfam: Immunoglobulin domain [PF13927.8, score=96.3]; Immunoglobulin I-set domain [PF07679.18, score=82.1]; Immunoglobulin V-set domain [PF07686.19, score=63.8]; Immunoglobulin domain [PF00047.27, score=57.8]; Immunoglobulin domain [PF13895.8, score=55.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=88.6, Expect=8e-18]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=92.0, Expect=5e-19]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=88.6, Expect=6e-18]} {Dmel: FBgn0000071, Ama, Amalgam, [RH, Score=111, Expect=7e-27]} {Celegans: WBGene00004372, rig-5, NeuRonal IGCAM, [RH, Score=98.2, Expect=6e-22]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=64.3, Expect=1e-10]} {RNA1310_49122} {RNA815_40619} |
| 8. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 2.587 | 0.861 | - | - | 0.772 | 0.954 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
| 9. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
2.572 | 0.811 | - | - | 0.794 | 0.967 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
| 10. | MligTC455_40065 | 58 | 1.22 | Mlig455_069280 | Neo: - Age: Up-Down-Up |
2.565 | - | - | 0.782 | 0.813 | 0.970 | - | Mlig455_069280 {REF} {Length: 3092} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=35.7]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.3]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [Score=236, Expect=1e-67]} {RNA1509_48196} {RNA1310_30411, RNA1509_48196} {RNA1509_48196, RNA815_45200} | |
| 11. | MligTC455_17609 | 87 | 1.82 | Mlig455_059630, Mlig455_059644 | Neo: - Age: Up-Down-Down |
GALR2 | 2.545 | - | - | 0.872 | 0.716 | 0.957 | - | Mlig455_059630 {REF} {Length: 3780} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} Mlig455_059644 {REF} {Length: 3887} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} |
| 12. | MligTC455_26832 | 211 | 4.39 | Mlig455_000690 | Neo: - Age: Down-Up-Down |
ANK3 | 2.456 | 0.728 | - | - | 0.760 | 0.968 | - | Mlig455_000690 {REF} {Length: 2225} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=184.0]; Ankyrin repeats (many copies) [PF13637.8, score=128.0]; Ankyrin repeat [PF00023.32, score=96.2]; Ankyrin repeats (many copies) [PF13857.8, score=94.5]; Ankyrin repeat [PF13606.8, score=92.4]; SOCS box [PF07525.18, score=29.0]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=120, Expect=6e-28]; ENSG00000135299, ANKRD6, ankyrin repeat domain 6, [Score=119, Expect=7e-28]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=122, Expect=1e-28]; ENSMUSG00000040183, Ankrd6, ankyrin repeat domain 6, [Score=122, Expect=6e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=121, Expect=1e-28]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=97.4, Expect=6e-21]} {Smed: dd_Smed_v6_17293_0_1, dd_Smed_v6_17293_0_1, [RH, Score=549, Expect=0.0]} {RNA1509_43489} {RNA1310_16486.1} {RNA815_13229} |
| 13. | MligTC455_32903 | 29 | 0.6 | Mlig455_037926 | Neo: - Age: - |
2.403 | - | - | 0.708 | 0.724 | 0.971 | - | Mlig455_037926 {REF} {Length: 1892} {RNA1310_57340} {RNA815_53132} | |
| 14. | MligTC455_15837 | 58 | 1.21 | Mlig455_058574 | Neo: - Age: Up-Down-Up |
PLEKHG5 | 1.86 | 0.897 | - | - | - | 0.963 | - | Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538} |
| 15. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
1.853 | 0.885 | - | - | - | 0.968 | - | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
| 16. | MligTC455_20028 | 492 | 10.25 | Mlig455_060293, Mlig455_065638 | Neo: - Age: logFC(26M/2M)=-0.541 Region-enriched R2: 1.959/0.01794 |
LRRC55 | 1.852 | - | - | - | 0.872 | 0.980 | - | Mlig455_060293 {REF} {Length: 2403} {Pfam: Leucine rich repeat [PF13855.8, score=64.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.3]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=59.7, Expect=4e-09]; ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=58.5, Expect=6e-09]; ENSMUSG00000020105, Lrig3, leucine-rich repeats and immunoglobulin-like domains 3, [Score=57.0, Expect=4e-08]} {Dmel: FBgn0033250, CG14762, [Score=63.2, Expect=2e-10]} {RNA1509_43260} {RNA1310_15302, RNA1509_43260} {RNA1509_43260, RNA815_13279} Mlig455_065638 {REF} {Length: 2056} {Pfam: Leucine rich repeat [PF13855.8, score=62.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.6]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=61.2, Expect=1e-09]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=60.1, Expect=2e-09]} {Dmel: FBgn0033250, CG14762, [Score=62.4, Expect=5e-10]} {RNA1509_43260} {RNA1310_15302} {RNA815_13279} |
| 17. | MligTC455_07327 | 46 | 0.95 | Mlig455_001874, Mlig455_001949 | Neo: - Age: - |
1.85 | - | - | 0.878 | - | 0.972 | - | Mlig455_001874 {REF} {Length: 1082} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.3]} {Celegans: WBGene00019444, frpr-11, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.4, Expect=3e-09]} {RNA1310_94087} {RNA815_48529} Mlig455_001949 {REF} {Length: 2058} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.4]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.0, Expect=4e-09]} {RNA1509_46461} {RNA1310_94087} {RNA815_57978} |
|
| 18. | MligTC455_47481 | 208 | 4.33 | Mlig455_066050 | Neo: - Age: - Region-enriched R2: 3.601/0.00192 |
1.848 | - | - | - | 0.876 | 0.972 | - | Mlig455_066050 {REF} {Length: 1418} {RNA1310_25309} {RNA815_22558.1} | |
| 19. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
1.84 | 0.881 | - | - | - | 0.959 | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
| 20. | MligTC455_41556 | 259 | 5.39 | Mlig455_007065 | Neo: - |
FOXC2 | 1.836 | - | - | - | 0.863 | 0.973 | - | Mlig455_007065 {REF} {Length: 3394} {Pfam: Forkhead domain [PF00250.20, score=132.6]} {Human: ENSG00000176692, FOXC2, forkhead box C2, [RH, Score=214, Expect=9e-62]; ENSG00000054598, FOXC1, forkhead box C1, [RH, Score=207, Expect=1e-58]} {Mouse: ENSMUSG00000050295, Foxc1, forkhead box C1, [RH, Score=217, Expect=2e-62]; ENSMUSG00000046714, Foxc2, forkhead box C2, [RH, Score=216, Expect=2e-62]} {Dmel: FBgn0014143, croc, crocodile, [RH, Score=191, Expect=3e-53]} {Celegans: WBGene00006853, unc-130, [Score=158, Expect=5e-43]} {Smed: dd_Smed_v6_16297_0_1, dd_Smed_v6_16297_0_1, [RH, Score=213, Expect=5e-61]} {RNA1509_45187} {RNA1310_22875.1} {RNA815_10125} |
| 21. | MligTC455_17468 | 54 | 1.13 | Mlig455_013421 | Neo: - Age: - Region-enriched R2: 9.270/0.00000 |
LUZP4 | 1.835 | 0.879 | - | - | - | 0.956 | - | Mlig455_013421 {REF} {Length: 1578} {Human: ENSG00000102021, LUZP4, leucine zipper protein 4, [RH, Score=62.8, Expect=5e-11]} {RNA1310_64423.1} {RNA815_29788} |
| 22. | MligTC455_09073 | 29 | 0.6 | Mlig455_001705 | Neo: - Age: - |
1.827 | - | - | 0.871 | - | 0.956 | - | Mlig455_001705 {REF} {Length: 206} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35647} | |
| 23. | MligTC455_14720 | 53 | 1.1 | Mlig455_033113 | Neo: - Age: - |
1.823 | - | - | 0.862 | - | 0.961 | - | Mlig455_033113 {REF} {Length: 2568} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=152.2]} {Celegans: WBGene00016063, delm-2, DEgenerin Linked to Mechanosensation, [Score=53.9, Expect=3e-07]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [RH, Score=216, Expect=7e-63]} {RNA1310_23517.1} {RNA815_11158} | |
| 24. | MligTC455_43554 | 87 | 1.81 | Mlig455_007397, Mlig455_007495 | Neo: - Age: - Region-enriched R2: 5.819/0.00092 |
KCNMA1 | 1.823 | 0.854 | - | - | - | 0.969 | - | Mlig455_007397 {REF} {Length: 4419} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.4]; Ion transport protein [PF00520.33, score=59.4]; Ion channel [PF07885.18, score=53.7]; TrkA-N domain [PF02254.20, score=19.8]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [RH, Score=1128, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [RH, Score=1121, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [RH, Score=1205, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [RH, Score=1127, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [RH, Score=1165, Expect=0.0]} {RNA1509_27885} {RNA1310_2876} {RNA815_9989} Mlig455_007495 {REF} {Length: 4518} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.4]; Ion transport protein [PF00520.33, score=59.7]; Ion channel [PF07885.18, score=53.6]; TrkA-N domain [PF02254.20, score=20.1]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [RH, Score=1134, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [RH, Score=1128, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [RH, Score=1212, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [RH, Score=1129, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [RH, Score=1165, Expect=0.0]} {RNA1509_27885} {RNA1310_2876} {RNA815_9989} |
| 25. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 1.821 | 0.837 | - | - | - | 0.984 | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
| 26. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
1.812 | 0.851 | - | - | - | 0.961 | - | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
| 27. | MligTC455_45231 | 73 | 1.52 | Mlig455_027244 | Neo: - Age: Up-Down-Down |
SLC16A14 | 1.812 | 0.844 | - | - | - | 0.968 | - | Mlig455_027244 {REF} {Length: 2892} {Pfam: Major Facilitator Superfamily [PF07690.18, score=114.7]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=148, Expect=8e-38]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=3e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=312, Expect=1e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=301, Expect=7e-94]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=198, Expect=1e-55]} {RNA1310_24115} {RNA815_15685} |
| 28. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 1.806 | 0.823 | - | - | - | 0.983 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
| 29. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.803 | - | - | - | 0.817 | 0.986 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
| 30. | MligTC455_14310 | 27 | 0.56 | Mlig455_021495 | Neo: - Age: - Regeneration-upregulated R2: 3.309 Regeneration-enriched R2: 3.309 |
1.798 | 0.835 | - | - | - | 0.963 | - | Mlig455_021495 {REF} {Length: 4005} {RNA1509_54101} {RNA1310_16857} {RNA815_29628} | |
| 31. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.798 | 0.838 | - | - | - | 0.960 | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 32. | MligTC455_20200 | 47 | 0.97 | Mlig455_021962 | Neo: - Age: - |
KCNMA1 | 1.794 | 0.833 | - | - | - | 0.961 | - | Mlig455_021962 {REF} {Length: 3749} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=76.1]; Ion channel [PF07885.18, score=61.3]; Ion transport protein [PF00520.33, score=34.6]; Ligand-gated ion channel [PF00060.28, score=23.9]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=634, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=628, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=449, Expect=8e-139]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=444, Expect=2e-137]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=610, Expect=0.0]} {RNA1310_43306.1} {RNA815_38585} |
| 33. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
1.792 | 0.814 | - | - | - | 0.978 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
| 34. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 1.784 | 0.829 | - | - | - | 0.955 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
| 35. | MligTC455_38813 | 50 | 1.04 | Mlig455_008881 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.104/0.01060 |
THSD7A | 1.781 | 0.802 | - | - | - | 0.979 | - | Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350} |
| 36. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.769 | 0.797 | - | - | - | 0.972 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
| 37. | MligTC455_52061 | 1829 | 38.1 | Mlig455_057385, Mlig455_057408, Mlig455_059550 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.420 Region-enriched R2: 1.691/0.03738 |
1.765 | - | - | - | 0.793 | 0.972 | - | Mlig455_057385 {REF} {Length: 1281} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=39.4]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=36.7]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_057408 {REF} {Length: 2720} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=38.6]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=37.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_059550 {REF} {Length: 1173} {Pfam: Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=33.3]; Domain of unknown function (DUF4905) [PF16248.7, score=30.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} |
|
| 38. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
1.758 | - | - | - | 0.802 | 0.956 | - | Mlig455_045246 {REF} {Length: 719} | |
| 39. | MligTC455_31172 | 195 | 4.06 | Mlig455_028354 | Neo: - Age: - Region-enriched R5: 4.005/0.04475 |
1.755 | 0.779 | - | - | - | 0.976 | - | Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412} | |
| 40. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.751 | - | - | - | 0.800 | 0.951 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
| 41. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 1.751 | - | - | - | 0.793 | 0.958 | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
| 42. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
1.75 | - | - | - | 0.797 | 0.953 | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
| 43. | MligTC455_16975 | 57 | 1.18 | Mlig455_058291 | Neo: - Age: - |
1.749 | 0.799 | - | - | - | 0.950 | - | Mlig455_058291 {REF} {Length: 3460} {RNA1509_57514} {RNA1310_36771} {RNA815_52846} | |
| 44. | MligTC455_07350 | 69 | 1.43 | Mlig455_010387, Mlig455_028017 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-1.679 Region-enriched R4: 4.964/0.00341 |
1.748 | - | - | - | - | 0.963 | 0.785 | Mlig455_010387 {REF} {Length: 2742} {RNA1310_57879} {RNA815_55513} Mlig455_028017 {REF} {Length: 2442} {RNA1310_57879} |
|
| 45. | MligTC455_39012 | 61 | 1.27 | Mlig455_030044 | Neo: - Age: Up-Down-Up |
PLCB3 | 1.747 | 0.797 | - | - | - | 0.950 | - | Mlig455_030044 {REF} {Length: 5860} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=196.5]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=125.0]; PH domain [PF17787.3, score=121.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=32.2]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=823, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=823, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=811, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=666, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=681, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555} {RNA815_2033} |
| 46. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.746 | - | - | - | 0.791 | 0.955 | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
| 47. | MligTC455_35505 | 126 | 2.62 | Mlig455_018997, Mlig455_022533, Mlig455_055707 | Neo: - Age: - |
HRH2, SYT7 | 1.745 | - | - | 0.794 | - | 0.951 | - | Mlig455_018997 {REF} {Length: 4854} {Pfam: C2 domain [PF00168.32, score=156.5]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=271, Expect=9e-84]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=261, Expect=3e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=4e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=6e-60]} {RNA1310_29722} {RNA815_16467} Mlig455_022533 {REF} {Length: 1223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=80.1]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=68.6, Expect=4e-12]} {Mouse: ENSMUSG00000044338, Aplnr, apelin receptor, [Score=64.3, Expect=7e-11]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=63.9, Expect=9e-11]; ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=63.2, Expect=2e-10]} {Dmel: FBgn0039595, AstA-R2, Allatostatin A receptor 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=63.2, Expect=9e-11]} Mlig455_055707 {REF} {Length: 2803} {Pfam: C2 domain [PF00168.32, score=156.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=270, Expect=2e-83]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=259, Expect=4e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=2e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=4e-60]} {RNA1310_29722} {RNA815_16467} |
| 48. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
1.745 | 0.780 | - | - | - | 0.965 | - | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
| 49. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
1.744 | 0.793 | - | - | - | 0.951 | - | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
| 50. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
1.743 | - | - | - | 0.783 | 0.960 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
| 51. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
1.742 | - | - | - | 0.765 | 0.977 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
| 52. | MligTC455_23479 | 66 | 1.38 | Mlig455_010615 | Neo: - Age: Down-Down-Up |
1.741 | - | - | 0.748 | - | 0.993 | - | Mlig455_010615 {REF} {Length: 2310} {RNA1310_33311} {RNA815_31084} | |
| 53. | MligTC455_41919 | 125 | 2.61 | Mlig455_048053 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.173/0.00312 |
1.737 | 0.768 | - | - | - | 0.969 | - | Mlig455_048053 {REF} {Length: 2537} {Pfam: Innexin [PF00876.20, score=331.0]} {Dmel: FBgn0265274, Inx3, Innexin 3, [Score=88.2, Expect=1e-18]} {Celegans: WBGene00006749, unc-9, Innexin unc-9, [Score=254, Expect=8e-80]} {Smed: dd_Smed_v6_8019_0_1, dd_Smed_v6_8019_0_1, [Score=296, Expect=3e-95]} {RNA1509_58318} {RNA1310_9243} {RNA815_4486.1} | |
| 54. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
1.735 | - | - | - | 0.785 | 0.950 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
| 55. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
1.731 | - | - | - | 0.765 | 0.966 | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
| 56. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 1.731 | - | - | 0.757 | - | 0.974 | - | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 57. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 1.726 | - | - | - | 0.749 | 0.977 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
| 58. | MligTC455_16209 | 72 | 1.51 | Mlig455_020329 | Neo: - Age: - Region-enriched R2: 5.444/0.00658 |
1.725 | 0.744 | - | - | - | 0.981 | - | Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719} | |
| 59. | MligTC455_46885 | 72 | 1.49 | Mlig455_015138 | Neo: - Age: - |
PRKG2 | 1.724 | - | - | - | 0.758 | 0.966 | - | Mlig455_015138 {REF} {Length: 3064} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Cyclic nucleotide-binding domain [PF00027.31, score=128.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=118.5]; Kinase-like [PF14531.8, score=25.1]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=674, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=682, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=668, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=676, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
| 60. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
1.722 | - | - | - | 0.752 | 0.970 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
| 61. | MligTC455_08333 | 172 | 3.59 | Mlig455_025435, Mlig455_025445 | Neo: - Age: - |
TNS1 | 1.721 | 0.760 | - | - | - | 0.961 | - | Mlig455_025435 {REF} {Length: 4797} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=67.1]; C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=38.4]; SH2 domain [PF00017.26, score=36.5]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=257, Expect=2e-69]; ENSG00000136205, TNS3, tensin 3, [RH, Score=251, Expect=1e-67]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [RH, Score=256, Expect=1e-72]; ENSMUSG00000020422, Tns3, tensin 3, [RH, Score=251, Expect=1e-67]} {Dmel: FBgn0000244, by, blistery, [RH, Score=222, Expect=2e-60]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=243, Expect=6e-72]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=217, Expect=5e-59]} {RNA1509_43365} {RNA1310_7714, RNA1509_43365} {RNA1509_43365, RNA815_14514} Mlig455_025445 {REF} {Length: 1758} {Pfam: C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=37.0]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=191, Expect=2e-53]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=191, Expect=3e-51]; ENSMUSG00000037003, Tns2, tensin 2, [Score=187, Expect=4e-50]} {Dmel: FBgn0026379, Pten, Phosphatase and tensin homolog, [Score=67.8, Expect=1e-11]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=109, Expect=1e-24]} {RNA1509_44169} {RNA1310_10509} {RNA815_24170} |
| 62. | MligTC455_32501 | 34 | 0.71 | Mlig455_053552 | Neo: - Age: - Region-enriched R2: 9.313/0.01306 |
GRIA1 | 1.719 | - | - | - | 0.761 | 0.958 | - | Mlig455_053552 {REF} {Length: 4329} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.5]; Receptor family ligand binding region [PF01094.30, score=76.3]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=605, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=577, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=577, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=603, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=582, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=576, Expect=0.0]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=499, Expect=6e-161]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=504, Expect=2e-163]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=740, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
| 63. | MligTC455_24345 | 161 | 3.36 | Mlig455_001456 | Neo: - Age: - |
1.718 | 0.743 | - | - | - | 0.975 | - | Mlig455_001456 {REF} {Length: 3298} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.3]} {RNA1310_23364} {RNA815_42991} | |
| 64. | MligTC455_02931 | 215 | 4.47 | Mlig455_007216, Mlig455_007226, Mlig455_007449 | Neo: - Age: - |
DACH1 | 1.717 | - | - | - | 0.759 | 0.958 | - | Mlig455_007216 {REF} {Length: 1825} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.5]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=6e-60]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=213, Expect=5e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=193, Expect=5e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=164, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=237, Expect=9e-71]} {RNA1310_26896.1} {RNA815_36501} Mlig455_007226 {REF} {Length: 2460} {Pfam: SKI/SNO/DAC family [PF02437.19, score=117.2]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=9e-62]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=7e-62]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=191, Expect=2e-53]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=7e-46]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=1e-72]} {RNA1310_26896.1} {RNA815_23939} Mlig455_007449 {REF} {Length: 2275} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.6]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=1e-59]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=6e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=192, Expect=8e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=2e-70]} {RNA1310_26896.1} {RNA815_23939} |
| 65. | MligTC455_20113 | 4626 | 96.37 | Mlig455_032728 | Neo: - Age: - Region-enriched R2: 7.104/0.00000 |
ADAMTS4 | 1.713 | - | - | - | 0.751 | 0.962 | - | Mlig455_032728 {REF} {Length: 1834} {Pfam: Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=34.1]; Metallo-peptidase family M12 [PF13688.8, score=30.1]} {Human: ENSG00000158859, ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif 4, [Score=50.1, Expect=3e-06]; ENSG00000154734, ADAMTS1, ADAM metallopeptidase with thrombospondin type 1 motif 1, [Score=48.1, Expect=3e-06]} {Mouse: ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=50.1, Expect=2e-06]} {RNA1509_811} {RNA1310_18102.1} {RNA815_7066} |
| 66. | MligTC455_20114 | 4655 | 96.97 | Mlig455_032750 | Neo: - Age: - Region-enriched R2: 6.812/0.00000 |
ADAMTS7 | 1.712 | - | - | - | 0.751 | 0.961 | - | Mlig455_032750 {REF} {Length: 1794} {Pfam: Metallo-peptidase family M12 [PF13688.8, score=51.5]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=44.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=39.8]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=37.0]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=26.8]; ADAM cysteine-rich domain [PF17771.3, score=26.3]; Astacin (Peptidase family M12A) [PF01400.26, score=18.3]} {Human: ENSG00000136378, ADAMTS7, ADAM metallopeptidase with thrombospondin type 1 motif 7, [Score=72.4, Expect=1e-12]; ENSG00000134917, ADAMTS8, ADAM metallopeptidase with thrombospondin type 1 motif 8, [Score=72.0, Expect=1e-12]} {Mouse: ENSMUSG00000058145, Adamts17, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17, [Score=70.5, Expect=3e-12]; ENSMUSG00000031994, Adamts8, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8, [Score=70.1, Expect=3e-12]; ENSMUSG00000046169, Adamts6, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6, [Score=69.7, Expect=4e-12]; ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=68.2, Expect=1e-11]; ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0029791, CG4096, [Score=74.3, Expect=1e-13]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [Score=58.5, Expect=6e-09]} {RNA1509_811} {RNA1310_18102.1, RNA1509_811} {RNA1509_811, RNA815_7066} |
| 67. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
1.709 | - | - | - | 0.724 | 0.985 | - | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
| 68. | MligTC455_42784 | 842 | 17.55 | Mlig455_004621, Mlig455_004630, Mlig455_004657 | Neo: - Age: - Region-enriched R2: 2.895/0.00752 |
1.707 | - | - | - | 0.757 | 0.950 | - | Mlig455_004621 {REF} {Length: 1246} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} Mlig455_004630 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.2} {RNA815_16689.1} Mlig455_004657 {REF} {Length: 1250} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} |
|
| 69. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 1.702 | - | - | - | 0.717 | 0.985 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
| 70. | MligTC455_41430 | 65 | 1.35 | Mlig455_070915 | Neo: - Age: - |
BHLHE22 | 1.702 | 0.743 | - | - | - | 0.959 | - | Mlig455_070915 {REF} {Length: 1052} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=58.4]} {Human: ENSG00000180828, BHLHE22, basic helix-loop-helix family member e22, [RH, Score=135, Expect=4e-37]} {Mouse: ENSMUSG00000025128, Bhlhe22, basic helix-loop-helix family, member e22, [RH, Score=133, Expect=8e-37]; ENSMUSG00000045493, Bhlhe23, basic helix-loop-helix family, member e23, [RH, Score=129, Expect=1e-36]} {Dmel: FBgn0032651, Oli, Olig family, [RH, Score=135, Expect=4e-39]} {Celegans: WBGene00001961, hlh-17, Helix Loop Helix, [RH, Score=103, Expect=2e-28]} {Smed: dd_Smed_v6_12722_0_1, dd_Smed_v6_12722_0_1, [RH, Score=129, Expect=2e-37]} {RNA1310_107478} |
| 71. | MligTC455_25920 | 378 | 7.87 | Mlig455_006540 | Neo: - |
1.7 | 0.721 | - | - | - | 0.979 | - | Mlig455_006540 {REF} {Length: 1697} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
| 72. | MligTC455_53276 | 52 | 1.07 | Mlig455_032898 | Neo: - Age: - |
1.699 | 0.716 | - | - | - | 0.983 | - | Mlig455_032898 {REF} {Length: 473} {NoTransDecoderORF} {RNA1310_127585} {RNA815_54104} | |
| 73. | MligTC455_32613 | 115 | 2.4 | Mlig455_019212 | Neo: - Age: logFC(26M/2M)=-0.399 |
STAC | 1.698 | - | - | 0.740 | - | 0.958 | - | Mlig455_019212 {REF} {Length: 3658} {Pfam: Variant SH3 domain [PF14604.8, score=37.9]; SH3 domain [PF00018.30, score=37.8]; Variant SH3 domain [PF07653.19, score=22.2]} {Human: ENSG00000144681, STAC, SH3 and cysteine rich domain, [Score=64.3, Expect=3e-10]; ENSG00000141750, STAC2, SH3 and cysteine rich domain 2, [Score=63.2, Expect=1e-09]} {Mouse: ENSMUSG00000032502, Stac, src homology three (SH3) and cysteine rich domain, [Score=67.0, Expect=3e-11]} {Dmel: FBgn0263980, CG43729, [RH, Score=97.1, Expect=1e-20]} {Celegans: WBGene00006791, unc-57, Endophilin-A homolog, [Score=49.3, Expect=4e-07]} {Smed: dd_Smed_v6_14652_0_1, dd_Smed_v6_14652_0_1, [RH, Score=185, Expect=2e-48]} {RNA1509_45601} {RNA1310_13004, RNA1509_45601} {RNA1509_45601, RNA815_25263} |
| 74. | MligTC455_23977 | 63 | 1.31 | Mlig455_012689 | Neo: - Age: - Regeneration-downregulated R5: -6.245 Regeneration-depleted R5: -6.245 |
DRD2 | 1.697 | 0.738 | - | - | - | 0.959 | - | Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584} |
| 75. | MligTC455_41296 | 43 | 0.9 | Mlig455_021118 | Neo: - Age: - |
1.697 | 0.727 | - | - | - | 0.970 | - | Mlig455_021118 {REF} {Length: 2049} {RNA1509_59262} {RNA1310_31928} {RNA815_32415} | |
| 76. | MligTC455_13030 | 30 | 0.63 | Mlig455_030520 | Neo: - Age: - |
1.695 | 0.728 | - | - | - | 0.967 | - | Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217} | |
| 77. | MligTC455_15022 | 16 | 0.33 | Mlig455_040949 | Neo: - Age: - |
PRKAR2B | 1.694 | 0.724 | - | - | - | 0.970 | - | Mlig455_040949 {REF} {Length: 1526} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.5]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=190, Expect=5e-57]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=189, Expect=1e-56]; ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=188, Expect=2e-56]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=217, Expect=5e-68]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=130, Expect=3e-35]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=187, Expect=8e-57]} {RNA1310_91044} {RNA815_60658} |
| 78. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
1.693 | - | - | - | 0.731 | 0.962 | - | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
| 79. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
1.69 | - | - | - | 0.736 | 0.954 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
| 80. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 1.688 | - | - | - | - | 0.950 | 0.738 | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
| 81. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
1.688 | - | - | - | 0.727 | 0.961 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
| 82. | MligTC455_51271 | 681 | 14.19 | Mlig455_021899, Mlig455_021976, Mlig455_022029 | Neo: - Age: - Region-specific R2: 6.767 Region-enriched R2: 4.145/0.01904 |
FOXA2 | 1.688 | - | - | - | 0.735 | 0.953 | - | Mlig455_021899 {REF} {Length: 3015} {Pfam: Forkhead domain [PF00250.20, score=129.1]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=224, Expect=1e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=228, Expect=3e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=233, Expect=8e-70]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=197, Expect=9e-58]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=239, Expect=1e-72]} {RNA1509_29593, RNA1509_56864} {RNA1310_6263, RNA1509_29593, RNA1509_56864} {RNA1509_29593, RNA1509_56864, RNA815_8556} Mlig455_021976 {REF} {Length: 2892} {Pfam: Forkhead domain [PF00250.20, score=129.2]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=222, Expect=2e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=214, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=226, Expect=4e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=231, Expect=1e-69]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=238, Expect=1e-72]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} Mlig455_022029 {REF} {Length: 3066} {Pfam: Forkhead domain [PF00250.20, score=31.9]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=80.9, Expect=5e-17]; ENSG00000129514, FOXA1, forkhead box A1, [Score=80.1, Expect=7e-17]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=83.6, Expect=4e-18]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=80.1, Expect=3e-17]; ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=79.7, Expect=6e-17]} {Dmel: FBgn0000659, fkh, fork head, [Score=89.0, Expect=3e-20]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=72.8, Expect=9e-15]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=103, Expect=1e-25]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} |
| 83. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 1.685 | 0.725 | - | - | - | 0.960 | - | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
| 84. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 1.684 | 0.707 | - | - | - | 0.977 | - | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
| 85. | MligTC455_49123 | 58 | 1.21 | Mlig455_057651 | Neo: - Age: - |
ASIC1 | 1.678 | - | - | - | 0.704 | 0.974 | - | Mlig455_057651 {REF} {Length: 2608} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=188.4]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=71.2, Expect=3e-12]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=67.0, Expect=4e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=89.0, Expect=3e-18]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=65.9, Expect=4e-11]} {RNA1310_10141} {RNA815_10820} |
| 86. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
1.676 | - | - | - | 0.714 | 0.962 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
| 87. | MligTC455_41376 | 50 | 1.04 | Mlig455_057140 | Neo: - Age: Up-Down-Up |
EGR1 | 1.671 | 0.702 | - | - | - | 0.969 | - | Mlig455_057140 {REF} {Length: 3119} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=51.7]; Zinc-finger double domain [PF13465.8, score=50.3]; C2H2-type zinc finger [PF13894.8, score=38.1]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=23.3]; C2H2-type zinc finger [PF13912.8, score=21.2]} {Human: ENSG00000120738, EGR1, early growth response 1, [Score=159, Expect=3e-42]; ENSG00000179388, EGR3, early growth response 3, [Score=154, Expect=8e-42]} {Mouse: ENSMUSG00000038418, Egr1, early growth response 1, [Score=159, Expect=2e-42]; ENSMUSG00000033730, Egr3, early growth response 3, [Score=154, Expect=6e-42]} {Dmel: FBgn0003499, sr, stripe, [Score=159, Expect=2e-41]} {Celegans: WBGene00043705, egrh-2, EGR (Early Growth factor Response factor) Homolog, [Score=139, Expect=3e-39]} {Smed: dd_Smed_v6_7091_0_1, dd_Smed_v6_7091_0_1, [Score=132, Expect=4e-34]} {RNA1509_44884} {RNA1310_48721} {RNA815_42057} |
| 88. | MligTC455_42785 | 79 | 1.65 | Mlig455_004724 | Neo: - Age: Down-Up-Down |
1.67 | - | - | - | 0.705 | 0.965 | - | Mlig455_004724 {REF} {Length: 1460} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1, RNA1509_29447} {RNA1509_29447, RNA815_16689.1} | |
| 89. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
1.666 | - | - | - | 0.707 | 0.959 | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
| 90. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.665 | 0.710 | - | - | - | 0.955 | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
| 91. | MligTC455_42530 | 41 | 0.86 | Mlig455_064531 | Neo: - Age: - |
RASL12 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_064531 {REF} {Length: 4677} {Pfam: Ras family [PF00071.24, score=65.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=24.9]} {Human: ENSG00000103710, RASL12, RAS like family 12, [Score=88.6, Expect=3e-20]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=87.4, Expect=3e-20]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=89.4, Expect=3e-21]; ENSMUSG00000030222, Rerg, RAS-like, estrogen-regulated, growth-inhibitor, [Score=87.4, Expect=2e-20]} {Dmel: FBgn0035711, CG8519, [Score=88.6, Expect=6e-21]} {Celegans: WBGene00021811, ral-1, RAL (Ras-related GTPase) homolog, [Score=65.5, Expect=2e-12]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=87.8, Expect=6e-21]} {RNA1310_147102} |
| 92. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 0.992 | - | - | - | - | 0.992 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
| 93. | MligTC455_17596 | 37 | 0.77 | Mlig455_007172 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_007172 {REF} {Length: 1102} {RNA1509_49095} {RNA1310_50088} {RNA815_56889.1} | |
| 94. | MligTC455_23048 | 39 | 0.81 | Mlig455_057935, Mlig455_070733 | Neo: - |
SGSM1 | 0.992 | - | - | - | - | 0.992 | - | Mlig455_057935 {REF} {Length: 4312} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=82.6]; RUN domain [PF02759.21, score=76.3]; Rab-binding domain (RBD) [PF12068.10, score=76.0]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [RH, Score=372, Expect=6e-110]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [RH, Score=369, Expect=4e-113]} {Dmel: FBgn0031116, CG1695, [Score=383, Expect=8e-114]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=221, Expect=2e-59]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=479, Expect=3e-150]} {RNA1310_35495.2} {RNA815_26008} Mlig455_070733 {REF} {Length: 1948} {Pfam: Rab-binding domain (RBD) [PF12068.10, score=56.3]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=204, Expect=7e-55]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=201, Expect=1e-55]} {Dmel: FBgn0031116, CG1695, [Score=200, Expect=5e-54]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=115, Expect=2e-26]} {Smed: dd_Smed_v6_3307_0_1, dd_Smed_v6_3307_0_1, [Score=188, Expect=3e-50]} {RNA1310_49577} {RNA815_26008} |
| 95. | MligTC455_35627 | 10 | 0.22 | Mlig455_034447 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_034447 {REF} {Length: 2136} {NoTransDecoderORF} {RNA1310_24457} {RNA815_54561} | |
| 96. | MligTC455_13318 | 468 | 9.76 | Mlig455_037659 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_037659 {REF} {Length: 2609} {Smed: dd_Smed_v6_20776_0_1, dd_Smed_v6_20776_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1509_12918, RNA1509_42831} {RNA1310_7526.1, RNA1509_42831} {RNA1509_42831, RNA815_9598.1} | |
| 97. | MligTC455_29432 | 12 | 0.25 | Mlig455_010925, Mlig455_033161 | Neo: - Age: Up-Down-Down |
STON2 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_010925 {REF} {Length: 8069} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=150.8]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=1e-77]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=283, Expect=5e-79]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=381, Expect=2e-109]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=370, Expect=6e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=774, Expect=0.0]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} Mlig455_033161 {REF} {Length: 6984} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=18.6]} {Human: ENSG00000140022, STON2, stonin 2, [Score=103, Expect=1e-21]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=102, Expect=2e-21]} {Dmel: FBgn0016975, stnB, stoned B, [Score=124, Expect=4e-28]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=144, Expect=3e-34]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [Score=375, Expect=3e-108]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} |
| 98. | MligTC455_38967 | 71 | 1.48 | Mlig455_060741 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.569 Region-enriched R2: 3.815/0.00926 |
UTRN | 0.989 | - | - | - | - | 0.989 | - | Mlig455_060741 {REF} {Length: 4727} {Pfam: EF-hand [PF09069.13, score=127.4]; EF hand [PF09068.13, score=102.4]; Zinc finger, ZZ type [PF00569.19, score=37.7]; WW domain [PF00397.28, score=18.6]} {Human: ENSG00000152818, UTRN, utrophin, [RH, Score=493, Expect=5e-147]; ENSG00000198947, DMD, dystrophin, [RH, Score=489, Expect=1e-150]} {Mouse: ENSMUSG00000019820, Utrn, utrophin, [RH, Score=493, Expect=2e-156]; ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [RH, Score=487, Expect=3e-145]} {Dmel: FBgn0260003, Dys, Dystrophin, [RH, Score=516, Expect=4e-155]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [RH, Score=337, Expect=1e-95]} {Smed: dd_Smed_v6_5325_0_6, dd_Smed_v6_5325_0_6, [RH, Score=295, Expect=4e-82]} {RNA1509_38827} {RNA1310_24533} {RNA815_12379} |
| 99. | MligTC455_03732 | 6 | 0.12 | Mlig455_030369, Mlig455_030417 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_030369 {REF} {Length: 1440} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=51.6, Expect=3e-07]} {Celegans: WBGene00016149, frpr-3, FMRFamide Peptide Receptor family; VRFamide receptor 1, [Score=53.5, Expect=3e-08]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=116, Expect=2e-30]} Mlig455_030417 {REF} {Length: 2861} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=32.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=171, Expect=6e-49]} |
|
| 100. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.986 | - | - | - | - | 0.986 | - | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
There are 204 more genes with r >= 0.95